Some reports showed that low doses of VX-680 and other AurA inhibitor such as MLN8237 inhibited growth of CML cell lines without affecting BCR-ABL activity39, 41, 42, 43. Here, AURKA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.